Dilek YEKENKURUL, Nevin INCE, Mustafa YILDIRIM, Mehmet Ali SUNGUR, Elif EŞCAN, Fatih DAVRAN, Hasan Baki ALTINSOY, Betül DÖNMEZ, Guleser AKPİNAR

COVID-19 Enfeksiyonunda Ağırlaştırıcı Risk Faktörlerinin Araştırılması

Amaç: Koronavirüs hastalığı-2019, yaklaşık iki yıl önce Çin'de başlayan ancak tüm dünyayı etkisi altına alan bir salgına neden olmuştur. Koronavirüs hastalığı-2019 enfeksiyonu ile takip edilen hastaların değerlendirilmesi, ciddi enfeksiyon için risk faktörlerinin ve göstergelerinin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Koronavirüs hastalığı-2019 enfeksiyonu ile 15 Mart- 01 Haziran 2020 tarihleri arasında yatarak tedavi gören hastalar araştırıldı. Hastalar oksijen satürasyonlarına göre iki gruba ayrıldı; oksijen satürasyonu % 90'ın üzerinde olan hastalar grup 1, % 90 ve altı olan hastalar grup 2 olarak belirlendi. Bu iki grup ağırlaştırıcı risk faktörleri açısından karşılaştırıldı. Bulgular: Bu çalışmaya 90 hasta (46 kadın, 44 erkek) dahil edildi. Bilgisayarlı toraks tomografisinde orta-şiddetli pnömonik tutulum (p=0,002) ve yüksek ateş (p

Anahtar Kelimeler:

Koronavirüs hastalığı 2019, ağırlaştırıcı faktörler, oksijen satürasyonu

Investigation of Aggravating Risk Factors in COVID-19 Infection

Aim: Coronavirus disease-2019 caused an epidemic that started in China about two years ago but affected the whole world. It was aimed to evaluate patients followed up with coronavirus disease-2019 infection, to determine risk factors and indicators for severe infection. Material and Methods: Patients who received treatment as inpatient with coronavirus disease-2019 infection between March 15- June 01 2020 were investigated. Patients were divided into two groups according to their oxygen saturation; patients with oxygen saturation over 90% were group 1, patients with 90% or less were determined as group 2. This two groups were compared in terms of aggravating risk factors. Results: In this study, 90 patients (46 female, 44 male) were included. Moderate-severe pneumonic involvement in computed tomography of thorax (p=0.002) and high fever (p

Keywords:

Coronavirus disease-2019, aggravating factors, oxygen saturation,

PDF

___

Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020; 323(8): 709-10.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-33.
Republic of Turkey Ministry of Health Directorate General of Public Health, 2020. COVID-19 (SARS-CoV-2 infection) general information, epidemiology and diagnosis. Scientific Board Study. Avaible from:s URL: https://covid19.saglik.gov.tr/Eklenti/39551/0/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf Accessed January 12, 2021.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20.
Komurcuoglu B. Clinical and laboratory findings of COVID-19. Eurasian J Pulmonol. 2020; 22: 16-8.
Mizumoto K, Kagaya K, Chowell G. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China. BMC Med. 2020; 15(18): 217.
Bilgiç Z, Güner R. COVID-19: Pathogenesis, transmission routes and risk factors. Aktaş F, editor. COVID-19: Pandemic Lessons. 1st Edition. Ankara: Turkey Clinics; 2020. p.14-24.
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte Ratio as an Independent Risk Factor for Mortality in Hospitalized Patients With COVID-19. J Infect. 2020; 81(1): 6-12.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J of Infect Dis. 2020; 94: 91-5.
Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020; 7: 157.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71 (15): 762-8.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.
Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for COVID-19 severity. Rev Saude Publica. 2020; 54: 60.
Zhang JJY, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Clin Infect Dis. 2020; 71(16): 2199-206.
Günal Ö, Türe E, Bayburtlu M, Arslan U, Demirağ MD, Taşkın MH, et al. Evaluation of patients diagnosed with COVID-19 in terms of risk factors. Bulletin of Microbiology. 2020; 54(4): 575-82.
Republic of Turkey Ministry of Health Directorate General of Public Health, 2021. COVID-19 (SARS-CoV-2 infection) adult patient treatment. Scientific Board Study. Avaible from:s URL:https://covid19.saglik.gov.tr/Eklenti/42169/0/covid19rehberieriskinhastayonetimivetedavi20122021v6pdf.pdf Accessed December 20, 2021.
Karabıyık L. Intensive Care Scoring Systems. Turkish Journal of Intensive Care Medicine. 2010; 9(3): 129-43.
World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. Avaible from:s URL: https://covid19.who.int/ Accessed January 13, 2021.
Republic of Turkey Ministry of Health, 2021. COVID-19 Weekly Status Report 12.10.2020 - 18.10.2020 Turkey. Avaible from:s URL: https://covid19.saglik.gov.tr/Eklenti/39168/0/covid-19-haftalik-durum-raporu---42-haftapdf.pdf?_tag1=710A3D148C11F8852B0DDC1FB4EE49DAE667F46D#:~:text=T%C3%BCrkiye'de%20toplam%209.296%20COVID,%252%2C67'dir Accessed January 13, 2021.
Republic of Turkey Ministry of Health, General Directorate of Public Health. 2020. Drugs used in the treatment of COVID-19, drug interactions. Avaible from:s URL: https://covid19.saglik.gov.tr/Eklenti/37818/0/covid-19tedavisindekullanilanilaclar-ilacetkilesimleripdf.pdf Accessed January 13, 2021.
Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Rep. 2021; 9: 461-4.
Rider FK, Lebedeva AV, Mkrtchyan VR, Guekht AB. Epilepsy and COVID-19: patient management and optimization of antiepileptic therapy during pandemic. Zh Nevrol Psikhiatr Im S S Korsakova. 2020; 120(10): 100-7.